Centre for Chinese Herbal Medicine Drug Development and Beijing Tong Ren Tang collaborate to develop Chinese medicine

The Centre for Chinese Herbal Medicine Drug Development (CDD) established by HKBU has signed a Memorandum of Understanding (MOU) with Beijing Tong Ren Tang to conduct collaborative research based on Chinese medicine (CM) formulas.

The MOU signing ceremony was held at the Hong Kong Science Park on 4 January. Professor Terence Lau, Interim Chief Innovation Officer of HKBU, kicked off the ceremony by delivering a welcome speech. The MOU was signed by Professor Bian Zhaoxiang, Director of the CDD, and Mr Chen Fei, Chief Executive Officer and Executive Director of Beijing Tong Ren Tang Chinese Medicine Co Ltd. Both parties introduced their research domains and discussed the direction for further cooperation, with the objectives of cultivating a collaborative drug research platform for advancing traditional CM formulas with technologies and translating research outputs into new drugs. They will join hands to provide a talent grooming programme that will support the research platform and nurture local CM research talent.

Funded by the InnoHK initiative of the Innovation and Technology Commission, the CDD was set up to pursue innovative CM research and development, promote CM standardisation and internationalisation, and turn traditional CM into novel drugs. Beijing Tong Ren Tang, a time-honoured CM company with a research and development base in Hong Kong, has been continuously developing CM products and services as well as fostering the modernisation of CM.